Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03297125 : Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
PhasePhase 4
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Newly diagnosed glioblastoma (GBM), WHO grade IV.

Exclusion Criteria:

- Optune compliance < 75%; they would be excluded from the final analyses.

- History of craniectomy or significant skull defect (contraindication to Optune).

- Active implantable medical device (i.e. DBS, spinal cord stimulator, pacemaker,
defibrillator, vagus nerve stimulator, programmable shunt).

- Karnofsky Performance Status (KPS) < 60.
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557